UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | J | K | L | M | O | P | R | S | T | V | W | Y | Z
Number of items: 97.

A

Andrady, C; Sharma, SK; Chester, KA; (2011) Antibody-enzyme fusion proteins for cancer therapy. IMMUNOTHERAPY-UK , 3 (2) 193 - 211. 10.2217/IMT.10.90.

Arkenau, H-K; (2011) Capecitabine combined with oxaliplatin (CAPOX) in clinical practice: how significant is peripheral neuropathy? ANNALS OF ONCOLOGY , 22 (1) 239 - U282. 10.1093/annonc/mdq676.

Arkenau, HT; Kefford, R; Long, GV; (2011) Targeting BRAF for patients with melanoma. Br J Cancer , 104 (3) 392 - 398. 10.1038/sj.bjc.6606030.

Arkenau, HT; Nordman, I; Dobbins, T; Ward, R; (2011) Reporting time-to-event endpoints and response rates in 4 decades of randomized controlled trials in advanced colorectal cancer. Cancer , 117 (4) 832 - 840. 10.1002/cncr.25636.

B

Babu, B; Lee, M; Lee, L; Strobel, R; Brockway, O; Nickols, A; ... Lee, M; + view all (2011) Acetyl analogs of combretastatin A-4: Synthesis and biological studies. BIOORGAN MED CHEM , 19 (7) 2359 - 2367. 10.1016/j.bmc.2011.02.018.

Babu, B; Liu, Y; Plaunt, A; Riddering, C; Ogilvie, R; Westrate, L; ... Lee, M; + view all (2011) Design, synthesis and DNA binding properties of orthogonally positioned diamino containing polyamide f-IPI. BIOCHEM BIOPH RES CO , 404 (3) 848 - 852. 10.1016/j.bbrc.2010.12.073.

Babu, B; Ramos, J; Liu, Y; Chavda, S; Tzou, S; Brockway, O; ... Lee, M; + view all (2011) Design, synthesis, and DNA binding selectivity and affinity studies of the tetraamide PhIPI and its diamino analog PhIP*I. In: ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY.

Baraniskin, A; Munding, J; Schulmann, K; Meier, D; Porschen, R; Arkenau, HT; ... Reinacher-Schick, A; + view all (2011) Prognostic value of reduced SMAD4 expression in patients with metastatic colorectal cancer under oxaliplatin-containing chemotherapy: a translational study of the AIO colorectal study group. Clin Colorectal Cancer , 10 (1) 24 - 29. 10.3816/CCC.2011.n.003.

Beltran, L; Chaussade, C; Vanhaesebroeck, B; Cutillas, PR; (2011) Calpain interacts with class IA phosphoinositide 3-kinases regulating their stability and signaling activity. Proc Natl Acad Sci U S A , 108 (39) 16217 - 16222. 10.1073/pnas.1107692108.

Birkbak, NJ; Eklund, AC; Li, Q; McClelland, SE; Endesfelder, D; Tan, P; ... Swanton, C; + view all (2011) Paradoxical relationship between chromosomal instability and survival outcome in cancer. Cancer Res , 71 (10) 3447 - 3452. 10.1158/0008-5472.CAN-10-3667.

Brough, R; Frankum, JR; Sims, D; Mackay, A; Mendes-Pereira, AM; Bajrami, I; ... Ashworth, A; + view all (2011) Functional viability profiles of breast cancer. Cancer Discov , 1 (3) 260 - 273. 10.1158/2159-8290.CD-11-0107.

Brucoli, F; Hawkins, RM; James, CH; Wells, G; Jenkins, TC; Ellis, T; ... Thurston, DE; + view all (2011) Novel C8-linked pyrrolobenzodiazepine (PBD)-heterocycle conjugates that recognize DNA sequences containing an inverted CCAAT box. BIOORG MED CHEM LETT , 21 (12) 3780 - 3783. 10.1016/j.bmcl.2011.04.054.

Brunetto, A; Olmos, D; Arkenau, HT; Tan, D; Yap, T; de Bono, J; ... Kaye, S; + view all (2011) Perceptions and referral trends into phase I oncology trials: results of a clinical survey. J Oncol , 2011 861401 - ?. 10.1155/2011/861401.

C

Calvert, AH; (2011) Synthetic lethality in cancer treatment: Current status of PARP inhibitors. In: ANNALS OF ONCOLOGY. (pp. 13 - 13). OXFORD UNIV PRESS

Calvert, H; Azzariti, A; (2011) The clinical development of inhibitors of poly(ADP-ribose) polymerase. ANNALS OF ONCOLOGY , 22 i53 - i59. 10.1093/annonc/mdq667.

Cerone, MA; Burgess, DJ; Naceur-Lombardelli, C; Lord, CJ; Ashworth, A; (2011) High-throughput RNAi screening reveals novel regulators of telomerase. Cancer Res , 71 (9) 3328 - 3340. 10.1158/0008-5472.CAN-10-2734.

Chavda, S; Liu, Y; Babu, B; Davis, R; Sielaff, A; Ruprich, J; ... Lee, M; + view all (2011) Hx, a novel fluorescent, minor groove and sequence specific recognition element: Design, synthesis, and DNA binding properties of p-anisylbenzimidazole imidazole/pyrrole-containing polyamides. In: ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY.

Chavda, S; Liu, Y; Babu, B; Davis, R; Sielaff, A; Ruprich, J; ... Lee, M; + view all (2011) Hx, a Novel Fluorescent, Minor Groove and Sequence Specific Recognition Element: Design, Synthesis, and DNA Binding Properties of p-Anisylbenzimidazole-imidazole/pyrrole-Containing Polyamides. BIOCHEMISTRY-US , 50 (15) 3127 - 3136. 10.1021/bi102028a.

Chew, SK; Rad, R; Futreal, PA; Bradley, A; Liu, P; (2011) Genetic screens using the piggyBac transposon. Methods , 53 (4) 366 - 371. 10.1016/j.ymeth.2010.12.022.

Coward, J; Kulbe, H; Chakravarty, P; Leader, D; Vassileva, V; Leinster, DA; ... Balkwill, FR; + view all (2011) Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer. CLIN CANCER RES , 17 (18) 6083 - 6096. 10.1158/1078-0432.CCR-11-0945.

Cox, ST; Stephens, HAF; Fernando, R; Karasu, A; Harber, M; Howie, AJ; ... Little, A-M; + view all (2011) Major histocompatibility complex class I-related chain A allele mismatching, antibodies, and rejection in renal transplantation. HUMAN IMMUNOLOGY , 72 (10) 827 - 834. 10.1016/j.humimm.2011.05.004.

D

De Bono, JS; Logothetis, CJ; Molina, A; Fizazi, K; North, S; Chu, L; ... COU-AA-301 Investigators,; + view all (2011) Abiraterone and Increased Survival in Metastatic Prostate Cancer. NEW ENGL J MED , 364 (21) 1995 - 2005.

E

Ertemi, H; Mumtaz, FH; Howie, AJ; Mikhailidis, DP; Thompson, CS; (2011) Effect of Angiotensin II and its Receptor Antagonists on Human Corpus Cavernous Contractility and Oxidative Stress: Modulation of Nitric Oxide Mediated Relaxation. J UROLOGY , 185 (6) 2414 - 2420. 10.1016/j.juro.2011.02.2645.

F

Feng, H; Hu, B; Liu, KW; Li, Y; Lu, X; Cheng, T; ... Cheng, SY; + view all (2011) Activation of Rac1 by Src-dependent phosphorylation of Dock180(Y1811) mediates PDGFRα-stimulated glioma tumorigenesis in mice and humans. J Clin Invest , 121 (12) 4670 - 4684. 10.1172/JCI58559.

Fenton, TR; Gout, IT; (2011) Functions and regulation of the 70 kDa ribosomal S6 kinases. INT J BIOCHEM CELL B , 43 (1) 47 - 59. 10.1016/j.bioce1.2010.09.018.

Forster, MD; Dedes, KJ; Sandhu, S; Frentzas, S; Kristeleit, R; Ashworth, A; ... Molife, LR; + view all (2011) Treatment with olaparib in a patient with PTEN-deficient endometrioid endometrial cancer. Nat Rev Clin Oncol , 8 (5) 302 - 306. 10.1038/nrclinonc.2011.42.

Furstenberg, A; Walsh, SB; Howie, A; Jones, G; Unwin, RJ; (2011) Calcineurin-Inhibitor Induced Hypertension, Hyperkalaemia and Metabolic Acidosis Is Caused by Overactivity of the Sodium Chloride Cotransporter. In: AMERICAN JOURNAL OF TRANSPLANTATION. (pp. 406 - 406). WILEY-BLACKWELL

Furuse, J; Okusaka, T; Bridgewater, J; Taketsuna, M; Wasan, H; Koshiji, M; Valle, J; (2011) Lessons from the comparison of two randomized clinical trials using gemcitabine and cisplatin for advanced biliary tract cancer. Crit Rev Oncol Hematol , 80 (1) 31 - 39. 10.1016/j.critrevonc.2010.10.009.

G

Gillmore, R; Stuart, S; Kirkwood, A; Hameeduddin, A; Woodward, N; Burroughs, AK; Meyer, T; (2011) EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization. J Hepatol , 55 (6) 1309 - 1316. 10.1016/j.jhep.2011.03.007.

Goldstein, R; Meyer, T; (2011) Role of everolimus in pancreatic neuroendocrine tumors. Expert Rev Anticancer Ther , 11 (11) 1653 - 1665. 10.1586/era.11.145.

Grimmett, C; Bridgewater, J; Steptoe, A; Wardle, J; (2011) Lifestyle and quality of life in colorectal cancer survivors. QUAL LIFE RES , 20 (8) 1237 - 1245. 10.1007/s11136-011-9855-1.

H

Hartley, JA; (2011) The development of pyrrolobenzodiazepines as antitumour agents. EXPERT OPIN INV DRUG , 20 (6) 733 - 744. 10.1517/13543784.2011.573477.

Hartley, JM; Spanswick, VJ; Hartley, JA; (2011) Measurement of DNA damage in individual cells using the Single Cell Gel Electrophoresis (Comet) assay. Methods Mol Biol , 731 309 - 320. 10.1007/978-1-61779-080-5_25.

Haylock-Jacobs, S; Comerford, I; Bunting, M; Kara, E; Townley, S; Klingler-Hoffmann, M; ... McColl, SR; + view all (2011) PI3Kδ drives the pathogenesis of experimental autoimmune encephalomyelitis by inhibiting effector T cell apoptosis and promoting Th17 differentiation. J Autoimmun , 36 (3-4) 278 - 287. 10.1016/j.jaut.2011.02.006.

Hochdörfer, T; Kuhny, M; Zorn, CN; Hendriks, RW; Vanhaesebroeck, B; Bohnacker, T; ... Huber, M; + view all (2011) Activation of the PI3K pathway increases TLR-induced TNF-α and IL-6 but reduces IL-1β production in mast cells. Cell Signal , 23 (5) 866 - 875. 10.1016/j.cellsig.2011.01.012.

Holme, H; Nanduri, V; (2011) Superior vena cava obstruction: dangers of a missed diagnosis. J Paediatr Child Health , 47 (3) 150 - 151. 10.1111/j.1440-1754.2010.01741.x.

Hoorn, EJ; Walsh, SB; McCormick, JA; Furstenberg, A; Yang, CL; Roeschel, T; ... Ellison, DH; + view all (2011) The calcineurin inhibitor tacrolimus activates the renal sodium chloride cotransporter to cause hypertension. NAT MED , 17 (10) 1304 - U339. 10.1038/nm.2497.

Howie, AJ; (2011) Problems with 'focal segmental glomerulosclerosis'. Pediatr Nephrol , 26 (8) 1197 - 1205. 10.1007/s00467-010-1701-0.

J

Johansson, AM; Karlsson, MO; Standing, JF; Hill, N; Perisoglou, M; Whelan, J; (2011) A population pharmacokinetic/pharmacodynamic model of methotrexate and mucositis scores in osteosarcoma. Therapeutic Drug Monitoring , 33 (6) 711 - 718. 10.1097/FTD.0b013e31823615e1.

Juergens, H; Daw, NC; Geoerger, B; Ferrari, S; Villarroel, M; Aerts, I; ... Gualberto, A; + view all (2011) Preliminary efficacy of the anti-insulin-like growth factor type 1 receptor antibody figitumumab in patients with refractory Ewing sarcoma. J Clin Oncol , 29 (34) 4534 - 4540. 10.1200/JCO.2010.33.0670.

K

Kato, H; Seto, K; Kobayashi, N; Yoshinaga, K; Meyer, T; Takei, M; (2011) CCK-2/gastrin receptor signaling pathway is significant for gemcitabine-induced gene expression of VEGF in pancreatic carcinoma cells. LIFE SCI , 89 (17-18) 603 - 608. 10.1016/j.lfs.2011.07.019.

Khan, MS; El-Khouly, F; Toumpanakis, C; Meyer, T; Caplin, M; Luong, TV; (2011) Ki-67 is a Better Prognostic Marker than Mitotic Count in Neuroendocrine Tumors. In: NEUROENDOCRINOLOGY. (pp. 31 - 31).

Khan, MS; Tsigani, T; Garcia-Hernandez, J; Caplin, M; Meyer, T; (2011) Circulating Tumor Cells (CTCs) Correlate with Overall Survival in Neuroendocrine Tumors (NETs). In: NEUROENDOCRINOLOGY. (pp. 31 - 31).

Khan, MS; Tsigani, T; Rashid, M; Rabouhans, JS; Yu, D; Tu, VL; ... Meyer, T; + view all (2011) Circulating Tumor Cells and EpCAM Expression in Neuroendocrine Tumors. CLIN CANCER RES , 17 (2) 337 - 345. 10.1158/1078-0432.CCR-10-1776.

Kristeleit, RS; baird, R; venugopal, B; wilkins, D; maccormick, F; granata, R; ... de bono, J; + view all (2011) Cardiac effects in a first-in-human (FIH), pharmacokinetic (PK), pharmacodynamic (PD) phase I trial of JNJ-26481585, a second-generation oral hydroxamate histone deacetylase inhibitor (HDACi), in patients with refractory cancer. In: Molecular Cancer Therapeutics.

Kulkarni, S; Sitaru, C; Jakus, Z; Anderson, KE; Damoulakis, G; Davidson, K; ... Hawkins, PT; + view all (2011) PI3Kβ plays a critical role in neutrophil activation by immune complexes. Sci Signal , 4 (168) ra23 - ?. 10.1126/scisignal.2001617.

L

Lafont, E; Kitatani, K; Okazaki, T; Ségui, B; (2011) Regulation of death and growth signals at the plasma membrane by sphingomyelin synthesis: implications for hematological malignancies. Recent Pat Anticancer Drug Discov , 6 (3) 324 - 333.

Ledermann, JA; Raja, FA; (2011) Clinical trials and decision-making strategies for optimal treatment of relapsed ovarian cancer. Eur J Cancer , 47 Suppl 3 S104 - S115. 10.1016/S0959-8049(11)70154-X.

Lee, AJ; Endesfelder, D; Rowan, AJ; Walther, A; Birkbak, NJ; Futreal, PA; ... Swanton, C; + view all (2011) Chromosomal instability confers intrinsic multidrug resistance. Cancer Res , 71 (5) 1858 - 1870. 10.1158/0008-5472.CAN-10-3604.

Lemech, C; Arkenau, H-T; (2011) Biomarkers in advanced colorectal cancer: Challenges in translating clinical research into practice. Cancers , 3 (2) 1844 - 1860. 10.3390/cancers3021844. Gold open access

Lemech, CR; Kristeleit, RS; Arkenau, H; (2011) Novel Oncology drug development strategies in the era of personalised medicine. In: Drug Discovery and Development. InTech

Leoni, LM; Hartley, JA; (2011) Mechanism of Action: The Unique Pattern of Bendamustine-Induced Cytotoxicity. SEMIN HEMATOL , 48 (2) S12 - S23. 10.1053/j.seminhematol.2011.03.003.

Liccardi, G; Hartley, JA; Hochhauser, D; (2011) EGFR Nuclear Translocation Modulates DNA Repair following Cisplatin and Ionizing Radiation Treatment. CANCER RES , 71 (3) 1103 - 1114. 10.1158/0008-5472.CAN-10-2384. Gold open access

Liccardi, G.; (2011) Nuclear EGFR modulation of DNA repair. Doctoral thesis, UCL (University College London). Green open access
file

Liu, H; Wang, W; Chew, SK; Lee, SC; Li, J; Vassiliou, GS; ... Liu, P; + view all (2011) Stella-Cre mice are highly efficient Cre deleters. Genesis , 49 (8) 689 - 695. 10.1002/dvg.20741.

Lolkema, MP; Arkenau, HT; Harrington, K; Roxburgh, P; Morrison, R; Roulstone, V; ... de Bono, JS; + view all (2011) A phase I study of the combination of intravenous reovirus type 3 Dearing and gemcitabine in patients with advanced cancer. Clin Cancer Res , 17 (3) 581 - 588. 10.1158/1078-0432.CCR-10-2159.

Lowe, H.L.; (2011) Design, construction and evaluation of a humanised ADEPT system. Doctoral thesis, UCL (University College London).

M

Mahadevan, D; Plummer, R; Squires, MS; Rensvold, D; Kurtin, S; Pretzinger, C; ... Calvert, H; + view all (2011) A phase I pharmacokinetic and pharmacodynamic study of AT7519, a cyclin-dependent kinase inhibitor in patients with refractory solid tumors. ANN ONCOL , 22 (9) 2137 - 2143. 10.1093/annonc/mdq734.

Mansur, A; Little, MA; Oh, WC; Jacques, S; Nightingale, P; Howie, AJ; Savage, CO; (2011) Immune profile and Epstein-Barr virus infection in acute interstitial nephritis: an immunohistochemical study in 78 patients. Nephron Clin Pract , 119 (4) c293 - c300. 10.1159/000329671.

Marsh, D; Suchak, K; Moutasim, KA; Vallath, S; Hopper, C; Jerjes, W; ... Thomas, GJ; + view all (2011) Stromal features are predictive of disease mortality in oral cancer patients. J PATHOL , 223 (4) 470 - 481. 10.1002/path.2830.

Maughan, TS; Adams, RA; Smith, CG; Meade, AM; Seymour, MT; Wilson, RH; ... MRC COIN Trial Investigators,; + view all (2011) Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial. Lancet , 377 (9783) 2103 - 2114. 10.1016/S0140-6736(11)60613-2.

Melichar, B; Casado, E; Bridgewater, J; Bennouna, J; Campone, M; Vitek, P; ... Tabernero, J; + view all (2011) Clinical activity of patupilone in patients with pretreated advanced/metastatic colon cancer: results of a phase I dose escalation trial. Br J Cancer , 105 (11) 1646 - 1653. 10.1038/bjc.2011.438.

Meyer, C; Sevko, A; Ramacher, M; Bazhin, AV; Falk, CS; Osen, W; ... Umansky, V; + view all (2011) Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model. Proc Natl Acad Sci U S A , 108 (41) 17111 - 17116. 10.1073/pnas.1108121108.

O

Osawa, T; Davies, D; Hartley, JA; (2011) Mechanism of cell death resulting from DNA interstrand cross-linking in mammalian cells. CELL DEATH DIS , 2 , Article e187. 10.1038/cddis.2011.70. Gold open access

P

Pors, K; Loadman, PM; Shnyder, SD; Sutherland, M; Sheldrake, HM; Guino, M; ... Patterson, LH; + view all (2011) Modification of the duocarmycin pharmacophore enables CYP1A1 targeting for biological activity. CHEM COMMUN , 47 (44) 12062 - 12064. 10.1039/c1cc15638a.

Pacey, S; Wilson, RH; Walton, M; Eatock, MM; Hardcastle, A; Zetterlund, A; ... Judson, I; + view all (2011) A phase I study of the heat shock protein 90 inhibitor alvespimycin (17-DMAG) given intravenously to patients with advanced solid tumors. Clin Cancer Res , 17 (6) 1561 - 1570. 10.1158/1078-0432.CCR-10-1927.

Plummer, R; Wilson, RH; Calvert, H; Boddy, AV; Griffin, M; Sludden, J; ... Nishiya, T; + view all (2011) A Phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumours. BRIT J CANCER , 104 (4) 593 - 598. 10.1038/bjc.2011.6.

Poiroux, G; Pitié, M; Culerrier, R; Lafont, E; Ségui, B; Van Damme, EJ; ... Benoist, H; + view all (2011) Targeting of T/Tn antigens with a plant lectin to kill human leukemia cells by photochemotherapy. PLoS One , 6 (8) , Article e23315. 10.1371/journal.pone.0023315. Green and gold open access
file

Puzanov, I; Lee, W; Chen, AP; Calcutt, MW; Hachey, DL; Vermeulen, WL; ... Rothenberg, ML; + view all (2011) Phase I Pharmacokinetic and Pharmacodynamic Study of SJG-136, a Novel DNA Sequence Selective Minor Groove Cross-linking Agent, in Advanced Solid Tumors. CLIN CANCER RES , 17 (11) 3794 - 3802. 10.1158/1078-0432.CCR-10-2056.

R

Raja, FA; Griffin, CL; Qian, W; Hirte, H; Parmar, MK; Swart, AM; Ledermann, JA; (2011) Initial toxicity assessment of ICON6: a randomised trial of cediranib plus chemotherapy in platinum-sensitive relapsed ovarian cancer. BRIT J CANCER , 105 (7) 884 - 889. 10.1038/bjc.2011.334.

Rajkumar, V; Dearling, JL; Packard, A; Pedley, RB; (2011) Radioimmunotherapy: optimizing delivery to solid tumors. Ther Deliv , 2 (5) 567 - 572.

Ran, Y; Ethaar, E-E; Vineeth, R; Mathew, R; Barbara, PR; Erik, A; (2011) One-pot Formation of a I-125-labeled Trifunctional Reagent for Multiscale Imaging with Optical and Nuclear Techniques. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS , 54 S57 - S57.

Reid, JM; Buhrow, SA; Kuffel, MJ; Jia, L; Spanswick, VJ; Hartley, JA; ... Ames, MM; + view all (2011) Pharmacokinetics, pharmacodynamics and metabolism of the dimeric pyrrolobenzodiazepine SJG-136 in rats. CANCER CHEMOTH PHARM , 68 (3) 777 - 786. 10.1007/s00280-010-1517-4.

Rustin, G; Reed, N; Jayson, GC; Ledermann, JA; Adams, M; Perren, T; ... Kaye, S; + view all (2011) A phase II trial evaluating two schedules of sagopilone (ZK-EPO), a novel epothilone, in patients with platinum-resistant ovarian cancer. ANN ONCOL , 22 (11) 2411 - 2416. 10.1093/annonc/mdq780.

S

Salazar, R; Plummer, R; Oaknin, A; Robinson, A; Pardo, B; Soto-Matos, A; ... Calvert, AH; + view all (2011) Phase I study of weekly plitidepsin as 1-hour infusion combined with carboplatin in patients with advanced solid tumors or lymphomas. INVEST NEW DRUG , 29 (6) 1406 - 1413. 10.1007/s10637-010-9488-1.

Saravanan, K; Barlow, HC; Barton, M; Calvert, AH; Golding, BT; Newell, DR; ... Griffin, RJ; + view all (2011) Nucleoside Transport Inhibitors: Structure-Activity Relationships for Pyrimido[5,4-d]pyrimidine Derivatives That Potentiate Pemetrexed Cytotoxicity in the Presence of alpha(1)-Acid Glycoprotein. J MED CHEM , 54 (6) 1847 - 1859. 10.1021/jm101493z.

Short, SC; Giampieri, S; Worku, M; German, M; Sioftanos, G; Bourne, S; (2011) Rad51 inhibition is an effective means of targeting DNA repair in glioma models and CD133+ tumour derived cells. Neuro-Oncology , 13 (5) 487 - 499.

Siddiqui, GK; Maclean, AB; Elmasry, K; Fong, AWT; Morris, RW; Rashid, M; ... Boxer, GM; + view all (2011) Immunohistochemical expression of VEGF predicts response to platinum based chemotherapy in patients with epithelial ovarian cancer. ANGIOGENESIS , 14 (2) 155 - 161. 10.1007/s10456-010-9199-4.

Sims, D; Mendes-Pereira, AM; Frankum, J; Burgess, D; Cerone, MA; Lombardelli, C; ... Lord, CJ; + view all (2011) High-throughput RNA interference screening using pooled shRNA libraries and next generation sequencing. Genome Biol , 12 (10) R104 - ?. 10.1186/gb-2011-12-10-r104.

Sivabalasingham, S; Fersht, N; D'Souza, D; Rosenberg, I; Stacey, C; Davies, P; ... Short, S; + view all (2011) Preliminary Results from a Phase I/II Study of Intensity Modulated Radiotherapy in the Treatment of Meningiomas. CLIN ONCOL-UK , 23 (3) S53 - S53.

Smith, SW; Eardley, KS; Croft, AP; Nwosu, J; Howie, AJ; Cockwell, P; ... Savage, CO; + view all (2011) CD248+ stromal cells are associated with progressive chronic kidney disease. Kidney Int , 80 (2) 199 - 207. 10.1038/ki.2011.103.

Spencer, J; Amin, J; Coxhead, P; McGeehan, J; Richards, CJ; Tizzard, GJ; ... Guille, M; + view all (2011) Size Does Matter. Sterically Demanding Metallocene-Substituted 3-Methylidene-Oxindoles Exhibit Poor Kinase Inhibitory Action. ORGANOMETALLICS , 30 (11) 3177 - 3181. 10.1021/om200278j.

T

Taylor, RM; Grieve, A; Gibson, F; Dhawan, A; Franck, LS; (2011) Parental assessment of adolescent quality of life: can it replace self-assessment? Qual Life Res , 20 (10) 1715 - 1720. 10.1007/s11136-011-9904-9.

Thirlwell, C; Schulz, L; Eymard, M; Luong, TV; Meyer, T; Davidson, B; ... Beck, S; + view all (2011) Integrated Genome-Wide DNA Methylation and mRNA Expression Analysis of Pancreatic NETs Identifies Differential Activation of the Hypoxia Inducible Factor (HIF) Pathway between Low and Intermediate Grade Tumors. In: NEUROENDOCRINOLOGY. (pp. 12 - 13).

V

van Zyl-Smit, RN; Binder, A; Meldau, R; Mishra, H; Semple, PL; Theron, G; ... Dheda, K; + view all (2011) Comparison of Quantitative Techniques including Xpert MTB/RIF to Evaluate Mycobacterial Burden. PLOS ONE , 6 (12) , Article e28815. 10.1371/journal.pone.0028815. Green and gold open access
file

Vazquez, I; Bridgewater, J; (2011) Nonsurgical therapy of biliary tract cancer. Curr Opin Gastroenterol , 27 (3) 258 - 261. 10.1097/MOG.0b013e3283454f09.

W

Wang, AT; Sengerova, B; Cattell, E; Inagawa, T; Hartley, JM; Kiakos, K; ... McHugh, PJ; + view all (2011) Human SNM1A and XPF-ERCC1 collaborate to initiate DNA interstrand cross-link repair. GENE DEV , 25 (17) 1859 - 1870. 10.1101/gad.15699211.

Wen, PJ; Osborne, SL; Zanin, M; Low, PC; Wang, HT; Schoenwaelder, SM; ... Meunier, FA; + view all (2011) Phosphatidylinositol(4,5)bisphosphate coordinates actin-mediated mobilization and translocation of secretory vesicles to the plasma membrane of chromaffin cells. Nat Commun , 2 491 - ?. 10.1038/ncomms1500.

Westbury, CB; Sahlberg, KK; Borresen-Dale, AL; Isacke, CM; Yarnold, JR; (2011) Gene expression profiling of human dermal fibroblasts exposed to bleomycin sulphate does not differentiate between radiation sensitive and control patients. RADIAT ONCOL , 6 , Article 42. 10.1186/1748-717X-6-42. Gold open access

Whelan, JS; Gelderblom, AH; Jinks, R; Sydes, M; Bramwell, VH; van Glabbeke, M; ... Taminiau, AHM; + view all (2011) Survival after recurrent osteosarcoma: data from 3 European Osteosarcoma Intergroup randomised controlled trials. Eur J Cancer (47) 895 - 902.

Whelan, JS; Jinks, RC; McTiernan, A; Sydes, MR; Hook, JM; Trani, L; ... Gelderblom, H; + view all (2011) Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials. Ann Oncol 10.1093/annonc/mdr491.

Whelan, JS; Miller, R; (2011) Lung carcinoma with hypertropic osteoarthropathy in a teenager. Rare Tumours , 3:e8

Whiteford, JR; Xian, X; Chaussade, C; Vanhaesebroeck, B; Nourshargh, S; Couchman, JR; (2011) Syndecan-2 is a novel ligand for the protein tyrosine phosphatase receptor CD148. Mol Biol Cell , 22 (19) 3609 - 3624. 10.1091/mbc.E11-02-0099.

Wykosky, J; Fenton, T; Furnari, F; Cavenee, WK; (2011) Therapeutic targeting of epidermal growth factor receptor in human cancer: successes and limitations. Chin J Cancer , 30 (1) 5 - 12. Gold open access

Y

Yan, R; El-Emir, E; Rajkumar, V; Robson, M; Jathoul, AP; Pedley, RB; Arstad, E; (2011) One-Pot Synthesis of an I-125-Labeled Trifunctional Reagent for Multiscale Imaging with Optical and Nuclear Techniques. ANGEW CHEM INT EDIT , 50 (30) 6793 - 6795. 10.1002/anie.201102072.

Yong, MY; Gonzalez-Beltran, A; Begent, R; (2011) Establishing a knowledge trail from molecular experiments to clinical trials. NEW BIOTECHNOL , 28 (5) 464 - 480. 10.1016/j.nbt.2011.03.016.

Z

Zhang, EZ; Povazay, B; Laufer, J; Alex, A; Hofer, B; Pedley, B; ... Drexler, W; + view all (2011) Multimodal photoacoustic and optical coherence tomography scanner using an all optical detection scheme for 3D morphological skin imaging. Biomed Opt Express , 2 (8) 2202 - 2215. 10.1364/BOE.2.002202.

This list was generated on Sun Aug 24 03:21:09 2014 BST.